Anirban Basu

Stergachis Family Endowed Professor & Director, The CHOICE Institute ( UW, Seattle, @amstatNews Fellow, @nberpubs RA. (he/him) 🐻 ⬇️

[Anirban Basu @Basucally]

USING RACE IN CLINICAL ALGORITHMS

Started during the heights of pandemic, this paper has been a labor of love for me for the last 3 years… finally out at @ScienceAdvances

@UW_Pharmacy #UWCHOICE

https://t.co/5NrfzlCU7v

Some discussions…

🧵 1/

[Anirban Basu @Basucally]

A key statistic to remember is that Titans plays about 70-75 defensive snaps/week, Bears play about 50-60… a big opportunity for Simmons to continue showing his impact!
#dabears @WaddleandSilvy

[Anirban Basu @Basucally]

@KhoaVuUmn ,

[Anirban Basu @Basucally]

@pedrohcgs Classic null effect, even though policy shock time is left ambiguous.

[Ari Hoffman @thehoffather]

BREAKING: Seattle’s business community is putting City Hall on notice over public safety.

CEOs from Microsoft, Starbucks, Costco, Nordstrom, T-Mobile, Alaska Airlines, Zillow, the Seattle Mariners, Puget Sound Energy and others signed a letter demanding Mayor Katie Wilson and the City Council take action to address public safety

They’re calling for CCTV cameras, more police patrols, a 7-minute priority 911 response standard, crackdowns on open-air drug markets, treatment or prosecution for repeat drug offenders, clearing encampments near schools and parks — and a public safety action plan within 100 days with measurable goals and monthly reports.

The letter specifically calls out Wilson's abysmal 34% approval numbers

[Anirban Basu @Basucally]

@TylerSbrt @DongNguyeb @yudapearl @f2harrell Randomization is the only mechanism to identify “a” causal effect of an intervention. In a controlled environment, such as RCT, the causal effect generated may not inform certain decisions. It may also not be generalizable to the population for which you want to make decision

[Anirban Basu @Basucally]

@yudapearl @f2harrell There have been some discussion on this front under the pragmatic trial discussions.. one example is https://t.co/IieoOXwY4E, but there are many others. RCTs definitely have valuable uses, less valuable in social science, IMHO.

[Austin Denteh @austin_denteh]

Happy to share my paper with Nicardo McInnis, now published in the Journal of Population Economics. We find childhood Food Stamp Program exposure reduced later-life fertility among men at older ages, especially in disadvantaged families.

Article: https://t.co/tDxXbHQzpH

[Anirban Basu @Basucally]

@InfectDiseaseAd @UW_Pharmacy .@KyuQLee

[Anirban Basu @Basucally]

There goes the demise of log-OLS regressions..

[NBER @nberpubs]

Total factor productivity growth is conditionally additive, not exponential, from Callum J. Jones, David López-Salido, and @ThomasPHI2 https://t.co/mPY6Ec41X9

[ISPOR @ISPORorg]

Congratulations to Beth Devine, PhD, PharmD, MBA, MSc, as she moves into the role of ISPOR President (2026-2027). #HEOR #healthcare #leaders #leadership
https://t.co/X9pv0idPaf

[Jing Li 李婧 @JingLiUW]

Now accepting submissions for the 11th Workshop in Behavioral and Experimental Health Economics (Dec 7-8, University of Washington, Seattle) @UWCHOICE.

Deadline: Aug 31, Submit here: https://t.co/GUu6WddhIz

#BehavioralEcon #HealthEcon

@cawley_john @Basucally @DanielWiesen1

[Anirban Basu @Basucally]

@4ntonioR @jondr44 @instrumenthull @NeumarkEcon @arindube @attilalindner @benzipperer These seem to be substantially different across outcome specifications! Again I have hard time interpreting what changes in E(log(emp/pop)) is showing me.

[Anirban Basu @Basucally]

@jondr44 @instrumenthull @NeumarkEcon @4ntonioR @arindube @attilalindner @benzipperer The estimands identify different parameters I think, even though the estimates may be similar in this case. I agree Emp/Pop does not make sense , and Emp, adjusting for Pop, is better option (@jmwooldridge Possion /binomial discussions)

[Anirban Basu @Basucally]

@btshapir Dribing?

[Anirban Basu @Basucally]

@anup_malani @cremieuxrecueil https://t.co/yqsqoREvge

[Anirban Basu @Basucally]

@Jabaluck What do you think will be in the utility function of a future AGI?

[AJHE @AJHE_journal]

New paper by @Basucally! How much of a drug's social value should go to innovators? 100% maximizes long-run welfare, but less if society prioritizes consumer surplus—especially when small countries can free-ride on others' R&D. https://t.co/ZCM5xuiXgs

[Annual Health Econometrics Workshop @HealthEconMetrx]

Call for papers! We are Excited that Partha Deb at CUNY has agreed to host the annual health economics workshop - Oct 1-3.

Please send cool papers to:
[email protected]